Ibm Retirement Fund Vertex Pharmaceuticals Inc Transaction History

Ibm Retirement Fund

$72.1 Million
Q2 2022

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$234.96 - $292.55 $954,407 - $1.19 Million	-4,062 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$221.42 - $260.97 $55,355 - $65,242	-250 Reduced 5.8%	4,062 $1.06 Million
Q4 2021 Jan 19, 2022	SELL	$177.01 - $223.45 $534,924 - $675,265	-3,022 Reduced 41.21%	4,312 $947,000
Q3 2021 Oct 05, 2021	BUY	$181.39 - $202.99 $4,897 - $5,480	27 Added 0.37%	7,334 $1.33 Million
Q2 2021 Jul 12, 2021	SELL	$187.49 - $221.1 $288,359 - $340,051	-1,538 Reduced 17.39%	7,307 $1.47 Million
Q1 2021 Apr 22, 2021	SELL	$207.02 - $241.31 $164,994 - $192,324	-797 Reduced 8.27%	8,845 $1.9 Million
Q4 2020 Jan 25, 2021	BUY	$207.01 - $276.09 $119,444 - $159,303	577 Added 6.37%	9,642 $2.28 Million
Q3 2020 Oct 16, 2020	BUY	$255.65 - $303.1 $606,913 - $719,559	2,374 Added 35.48%	9,065 $2.47 Million
Q2 2020 Jul 08, 2020	SELL	$225.48 - $295.8 $3,833 - $5,028	-17 Reduced 0.25%	6,691 $1.94 Million
Q1 2020 Apr 07, 2020	BUY	$199.77 - $247.81 $460,070 - $570,706	2,303 Added 52.28%	6,708 $1.6 Million
Q4 2019 Jan 07, 2020	SELL	$166.71 - $223.91 $25,006 - $33,586	-150 Reduced 3.29%	4,405 $964,000
Q3 2019 Nov 06, 2019	SELL	$166.23 - $187.09 $7,979 - $8,980	-48 Reduced 1.04%	4,555 $772,000
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $12,839 - $14,848	78 Added 1.72%	4,603 $844,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $4,584 - $5,451	28 Added 0.62%	4,525 $832,000
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $45,269 - $57,278	-298 Reduced 6.21%	4,497 $745,000
Q3 2018 Nov 07, 2018	SELL	$167.73 - $192.74 $120,094 - $138,001	-716 Reduced 12.99%	4,795 $924,000
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $95,883 - $111,833	-658 Reduced 10.67%	5,511 $937,000
Q1 2018 May 10, 2018	SELL	$151.6 - $177.13 $19,708 - $23,026	-130 Reduced 2.06%	6,169 $1.01 Million
Q4 2017 Feb 07, 2018	BUY	$137.28 - $155.55 $8,099 - $9,177	59 Added 0.95%	6,299 $1.04 Million
Q3 2017 Nov 07, 2017	BUY	$148.13 - $162.24 $924,331 - $1.01 Million	6,240	6,240 $1.05 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.

Account